Fed. Circ. Denies Lilly En Banc Review In Gemzar Feud
The denial, issued Monday, followed a Federal Circuit ruling in July sustaining the lower court's judgment against Lilly. Sun Pharmaceutical Industries Ltd. sued Lilly in 2007, challenging the patent-in-suit's valid in an effort to introduce a generic version of the drug.
In a dissent,...
To view the full article, register now.